TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
GRCL

Gracell Biotechnologies Inc.

Healthcare · Biotechnology

485.20$ -2.8% vs. previous close Closing price · As of: Aug 13, 2026

Ownership

Ownership Structure

Who owns Gracell Biotechnologies Inc. (GRCL)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 63.1%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 16.4%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 2.0%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 97Mio.

Largest Shareholders

Institutions

Institutions GRCL
Name Stake (%) Shares Change (%) Date
China Universal Asset Mgmt Co.Ltd 0.01 8,405 +380.8 12/31/2023
PNC Financial Services Group Inc 0.00 150 +0.0 12/31/2023

Funds

Funds GRCL
Name Stake (%) Shares Change (%) Date
Biotech Growth Ord 3.92 3,781,520 +0.0 05/31/2026
GAMCO Intl SICAV Merger Arbtrg I (USD) 0.47 450,208 -1.1 03/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?